Zepp Health Corp

We are a global smart wearable and health technology leader. Since our inception in 2013, we have established a strong global presence, particularly in Europe and the U.S. To date, we have shipped over 200 million units of smart wearable devices and served more than 53 million users in over 90 countries with device activation in more than 150 countries. In December 2013, we commenced our operations in China with a focus on developing, manufacturing and selling smart wearable devices. A year later, in December 2014, we incorporated Zepp Health Corporation, previously knowns as Huami Corporation, in the Cayman Islands as our offshore holding company to facilitate financing and offshore listing. On February 8, 2018, our ADSs commenced trading on the NYSE under the symbol HMI. In February 2021, we, through Anhui Shunyuan Xinke Management Consulting Partnership (Limited Partnership), one of our subsidiaries in China, acquired 29.99% of the total outstanding shares of Jiangsu Yitong, a PRC company listed in Shenzhen Stock Exchange, for an aggregate consideration of US$144.89 million in cash to expand the healthcare ecosystem for Chinese market in the long term. The transaction was completed in February 2021. In May 2022, we, through Anhui Shunyuan Xinke Management Consulting Partnership (Limited Partnership), acquired another 0.01% of the total outstanding shares of Jiangsu Yitong for an aggregate consideration of US$35,238. In February 2021, we rebranded ourselves from Huami Corporation to Zepp Health Corporation to emphasize our global recognition and expansion efforts.